Opgen Return on Equity

Opgen (OPGN) currently reports a ROE of 83.85%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore Opgen's ROE history and peer comparisons.

Opgen's ROE of 83.85% is higher than the Healthcare sector average of 22.01%. That is roughly 281.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Opgen's current 83.85% should be judged against Healthcare norms (sector average: 22.01%) and against OPGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 83.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Opgen, and consider following OPGN for alerts when major investors trade the stock.

Opgen is classified in the Healthcare sector. On ROE, it currently shows 83.85% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPGN with unrelated industries.